News
Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on ...
Zacks Investment Research on MSN12h
CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?Retail pharmacy powerhouse, CVS Health CVS, is advancing its digital-first strategy and investing in emerging technologies as part of its long-term growth plan. The company recently announced plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback